Phase III trial of gemcitabine, curcumin and Celebrex [celecoxib] in patients with advance or inoperable pancreatic cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib; Curcumin; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 06 Jul 2007 New trial record.
- 14 Jun 2007 Biomarkers information updated